CytoSorbents Closes $10 Million Debt Financing with Bridge Bank
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and organ failure in critically-ill and cardiac surgery patients around the world, announced that it has closed upon a $10 million senior debt facility with the Life Sciences Group of Bridge Bank, a division of Western Alliance Bank (NYSE: WAL).
CytoSorbents Corporation and its U.S. operating subsidiary, CytoSorbents Medical, Inc. entered into a Loan and Security Agreement with Bridge Bank, securing an initial $5 million 4-year term loan that was funded on June 30, 2016. Interest-only monthly payments are due for the first year and then monthly principal and interest payments are due through the remainder of the term. Prior to June 30, 2017, CytoSorbents has the ability, at its discretion, to receive an additional term loan of $5 million, provided certain conditions are met. If this occurs, the period of interest-only payments on both term loans will be extended by six months through January 31, 2018, followed by 30 months of straight line amortization through the July 1, 2020 maturity date. The Company intends to use the proceeds from the loan to provide working capital to fund ongoing operations and to support clinical trials.
“This non-dilutive financing further strengthens our balance sheet at an attractive cost of capital. Importantly, it will allow us to continue to pursue our aggressive growth strategy and clinical trial objectives as we increase product sales worldwide and move towards operating cash flow breakeven,” stated Ms. Kathleen P. Bloch, CPA, MBA, Chief Financial Officer of CytoSorbents Corporation. “We welcome this new relationship with Bridge Bank, a reputable and premier industry provider with a broad scope of financial services.”
“We have been following CytoSorbents for several years now, and believe they possess a truly innovative technology in the life sciences space which could transform critical care medicine and cardiac surgery and save lives throughout the world,” said Mr. Justin McDonie, Senior Vice President and Managing Director for Bridge Bank. “We are pleased to provide this growth capital at this important juncture in CytoSorbents’ evolution and look forward to helping make the company a success.”
About Bridge Bank and Western Alliance Bank (NYSE: WAL)
Bridge Bank is a division of Western Alliance Bank, the go-to-bank for business in its growing markets. Bridge Bank was founded in 2001 in Silicon Valley to offer a better way to bank for small-market and middle-market businesses from across many industries, as well as emerging technology companies and the private equity community. Geared to serving both venture-backed and non-venture-backed companies, Bridge Bank offers a broad scope of financial solutions including growth capital, equipment and working capital credit facilities, sustainable energy project finance, venture debt, treasury management, asset-based lending, SBA and commercial real estate loans, ESOP finance and a full line of international products and services. Based in San Jose, Bridge Bank has 10 offices in major markets across the country along with Western Alliance Bank's robust national platform of specialized financial services. Western Alliance Bank is the primary subsidiary of Phoenix-based Western Alliance Bancorporation. With $15 billion in assets, Western Alliance Bancorporation (NYSE: WAL) is one of the fastest-growing bank holding companies in the U.S. and recognized as #10 on the Forbes 2016 "Best Banks in America" list. For more information, visit www.bridgebank.com or follow us on Twitter @Bridgebank.
About CytoSorbents Corporation (NASDAQ: CTSO)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb®, is approved in the European Union with distribution in 34 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm" or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis, as well as in cancer immunotherapy. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. CytoSorb® has been used safely in more than 12,000 human treatments to date.
CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including HemoDefend™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites: http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as "may," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements in this press release represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, the risks discussed in our Annual Report on Form 10-K, filed with the SEC on March 9, 2016, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business. We caution you not to place undue reliance upon any such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required under the Federal securities laws.
Recent NewsBridge Bank Upsizes Capstone Turbine Facility to $15 MillionRestoration Robotics Secures $20 Million Loan and Security Agreement with Solar Capital Ltd. and Bridge BankCytoSorbents Refinances Existing Debt with New $15 Million Debt Facility with Bridge BankBridger acquires Old Mill BrickBIOLASE Secures $6 Million Revolving Line of Credit
Recent InsightsThe Biggest Trends in Hotel Franchising - 2017 EditionMobile Banking Helps Businesses On The GoConsider the Business Benefits of Payroll Cards — and Keep Employees HappyThe Treasury Manager Today: A Strategic Role for Changing TimesMilestone Offshore Wind Project Approved in Europe
Did you know? Bernard J. Cigrand is considered to be the “Father of Flag Day.” In 1885, he organized a group of sch… twitter.com/i/web/status/1… - 5 daysOur #LifeSciences Group is pleased to announce their most recent transaction with @Zipline_Medical a technology com… twitter.com/i/web/status/1… - 7 daysDue to the close proximity of the Golden State Warriors Championship Parade and activities, our Oakland branch will… twitter.com/i/web/status/1… - 1 week 1 day agoCongratulations to the @warriors on their back-to-back championship! Our employees in Oakland are very excited that… twitter.com/i/web/status/1… - 1 week 1 day agoWe were proud to sponsor last night’s SPUR event at San Pedro Market in downtown San Jose. You can learn more about… twitter.com/i/web/status/1… - 1 week 6 days agoAs presenting sponsor of the 8th Annual #sjsueconsummit we want to extend our gratitude and many #thanks to those w… twitter.com/i/web/status/1… - 2 weeks 4 days agoAre you wondering how the #economy can be as #healthy as ever if a lack of #housing is the #1 concern? You’re not a… twitter.com/i/web/status/1… - 3 weeks agoOn May 31, Dr. Christopher Thornberg, founder of Beacon Economics, will be at #sjsueconsummit providing an analysis… twitter.com/i/web/status/1… - 3 weeks 1 day agoCalifornia is now the 5th largest economy in the world, surpassing the UK. On 5/31, Dr. Thornberg, founder of Beaco… twitter.com/i/web/status/1… - 3 weeks 5 days agoThis #MemorialDay, we honor those who lost their lives to give us #freedom. pic.twitter.com/lKEzeg9YarHave you ever been in a car with a driver who has one foot on the accelerator and the other on the brakes? On 5/31,… twitter.com/i/web/status/9… - 3 weeks 5 days agoWe are a proud sponsor of the 19th Annual B. Riley FBR #InstitutionalInvestorConference, taking place May 23 - 24,… twitter.com/i/web/status/9… - 3 weeks 6 days agoOur Life Sciences Group is excited to announce Alastin Skincare, an innovative skincare company that has designed a… twitter.com/i/web/status/9… - 4 weeks agoinfo.bridgebank.com/economicsummit - about 1 month 1 week ago There's still time to register for the #sjsueconsummit featuring an analysis and forecast… twitter.com/i/web/status/9… - about 1 month 1 week agoAs a sponsor of the @PhilaPACT Enterprise Awards 25th Anniversary Dinner, we would like to congratulate our clients… twitter.com/i/web/status/9… - about 1 month 1 week agoBridge Bank is a proud sponsor of the Blacks 'n Business Blacks 'n Technology Awards Ceremony tonight. Congratulati… twitter.com/i/web/status/9… - about 1 month 2 weeks agoThank you @eastbayeda and @Oakland for hosting a great panel discussion during #smallbusinessweek twitter.com/eastbayeda/sta… - about 1 month 2 weeks agoinfo.bridgebank.com/economicsummit - about 1 month 2 weeks ago There's still time to register for the #sjsueconsummit featuring an analysis and forecast… twitter.com/i/web/status/9… - about 1 month 2 weeks agoOur Capital Finance team is excited to share their recent deal with our newest client, eero, the company that built… twitter.com/i/web/status/9… - about 1 month 2 weeks agoBuilding Blocks of Export Success is the educational workshop that our very own, Ken Rosenberg, will be speaking at… twitter.com/i/web/status/9… - about 1 month 2 weeks agoOur Life Sciences Group is proud to announce that our client, @CytoSorbents has refinanced their term loan. We look… twitter.com/i/web/status/9… - about 1 month 3 weeks ago♫ Happy Earth Day to you. Happy Earth Day to you. Happy Earth Day, dear Earth. Happy Earth Day to you! ♪ Joining… twitter.com/i/web/status/9… - about 1 month 4 weeks agoThis week, markets set aside geopolitics to focus on earnings and fundamentals. westernalliancebancorporation.com/bridge-bank-ho… - about 2 months agoWe are excited to announce, Ken Rosenberg, head of International #Banking, will be a moderator during the Asia Mari… twitter.com/i/web/status/9… - about 2 months 2 days agoBridge Bank is proud to be a wine table host at the Wine Tasting Networking Reception during the Western Private Eq… twitter.com/i/web/status/9… - about 2 months 3 days agoAs presenting sponsor, we invite you to attend the SJSU Economic Summit as Dr. Christopher Thornberg gives an analy… twitter.com/i/web/status/9… - about 2 months 4 days agoWe are so proud to be an attending sponsor of this year’s #Solar Power Finance & Investment Summit (March 20 -22) i… twitter.com/i/web/status/9… - about 2 months 4 weeks agoThe Federal Reserve is set to deliver its first rate hike of 2018, as markets await FOMC decision. westernalliancebancorporation.com/bridge-bank-ho… - about 3 months 1 day agoDid you know? The first record of a St. Patrick's Day parade, took place in New York in 1762. Today, it's the large… twitter.com/i/web/status/9… - about 3 months 5 days agoU.S. in focus as trade tensions linger. westernalliancebancorporation.com/bridge-bank-ho… - about 3 months 6 days agoMarkets shift their attention from politics to central banks this week, with decisions by the ECB, BoC, BoJ, and RB… twitter.com/i/web/status/9… - about 3 months 2 weeks agoWe're excited to announce that Bridge Bank's very own Dale Marie Golden at our Oakland branch has been nominated fo… twitter.com/i/web/status/9… - about 3 months 2 weeks agoOur client, @EksoBionics , has partnered with @Ford to help factory workers become more productive while avoiding f… twitter.com/i/web/status/9… - about 4 months 1 week agoIn addition to figuring out how to extend your stay in Florida, we hope your #FVCC2018 agenda included meeting our team!